These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29928016)

  • 1. In silico and in vitro analysis of boAP3d1 protein interaction with bovine leukaemia virus gp51.
    Corredor AP; González J; Baquero LA; Curtidor H; Olaya-Galán NN; Patarroyo MA; Gutiérrez MF
    PLoS One; 2018; 13(6):e0199397. PubMed ID: 29928016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agar gel immunodiffusion analysis using baculovirus-expressed recombinant bovine leukemia virus envelope glycoprotein (gp51/gp30(T-)).
    Lim SI; Jeong W; Tark DS; Yang DK; Kweon CH
    J Vet Sci; 2009 Dec; 10(4):331-6. PubMed ID: 19934599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1.
    Orlik O; Ban J; Hlavaty J; Altaner C; Kettmann R; Portetelle D; Splitter GA
    J Virol; 1997 Apr; 71(4):3263-7. PubMed ID: 9060692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the bovine leukemia virus envelope glycoprotein (gp51) by recombinant baculovirus and its use in an enzyme-linked immunosorbent assay.
    De Giuseppe A; Feliziani F; Rutili D; De Mia GM
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):147-51. PubMed ID: 14715562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient expression of a bovine leukemia virus envelope glycoprotein in plants by a recombinant TBSV vector.
    Zhumabek AT; Abeuova LS; Mukhametzhanov NS; Scholthof HB; Ramankulov YM; Manabayeva SA
    J Virol Methods; 2018 May; 255():1-7. PubMed ID: 29410083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies.
    Ban J; Czene S; Altaner C; Callebaut I; Krchnak V; Merza M; Burny A; Kettmann R; Portetelle D
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2457-61. PubMed ID: 1383413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification by Strep-Tactin affinity chromatography of a delete envelope gp51 protein of Bovine Leukaemia virus expressed in Sf21 insect cells.
    De Giuseppe A; Forti K; Feliziani F; Severi G; Cagiola M
    Protein J; 2010 Apr; 29(3):153-60. PubMed ID: 20232124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of common B cell epitope in bovine leukemia virus via high-throughput peptide screening system in infected cattle.
    Bai L; Otsuki H; Sato H; Kohara J; Isogai E; Takeshima SN; Aida Y
    Retrovirology; 2015 Dec; 12():106. PubMed ID: 26715158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an immunodominant region on the isolated bovine leukaemia virus (BLV) major envelope protein gp51 by monoclonal antibodies presumably not exposed during natural BLV infection.
    Platzer C; Siakkou H; Sober J; Kopp J; Scheve E; Rosenthal S
    Acta Virol; 1990 May; 34(3):246-55. PubMed ID: 1980398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and in vitro characterization of recombinant vaccinia viruses expressing bovine leukemia virus gp51 in combination with bovine IL4 or IL12.
    Von Beust BR; Brown WC; Estes DM; Zarlenga DS; McElwain TF; Palmer GH
    Vaccine; 1999 Jan; 17(4):384-95. PubMed ID: 9987178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and immunological characterization of the bovine leukemia virus (BLV) envelope glycoprotein (gp51) produced in Saccharomyces cerevisiae.
    Legrain M; Portetelle D; Dumont J; Burny A; Hilger F
    Gene; 1989 Jul; 79(2):227-37. PubMed ID: 2551774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface expression of the bovine leukemia virus-binding receptor on B and T lymphocytes is induced by receptor engagement.
    Lavanya M; Kinet S; Montel-Hagen A; Mongellaz C; Battini JL; Sitbon M; Taylor N
    J Immunol; 2008 Jul; 181(2):891-8. PubMed ID: 18606640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
    Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
    Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine lymphosarcoma: processing of bovine leukaemia virus-coded proteins.
    Mamoun RZ; Astier T; Guillemain B; Duplan JF
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2791-5. PubMed ID: 6319563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radioimmunoassay detecting the bovine leukaemia virus transmembrane protein gp30 and anti-gp30 antibodies in the serum of cattle.
    Bossmann H; Siakkou H; Ulrich R; Uckert W; Kraft R; Rosenthal S; Rosenthal HA
    Acta Virol; 1989 Mar; 33(2):113-20. PubMed ID: 2569806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of bovine leukemia virus from Moldovan dairy cattle.
    Pluta A; Rola-Łuszczak M; Kubiś P; Balov S; Moskalik R; Choudhury B; Kuźmak J
    Arch Virol; 2017 Jun; 162(6):1563-1576. PubMed ID: 28213870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Exposure of the major immunodominant epitope of the gp51 envelope protein of bovine leukosis virus on the surface of the hepatitis B core antigen capsid].
    Ul'rikh R; Borisova GP; Siakkou Kh; Plattser K; Ose VP; Berzin' IG; Dreĭlinia DE; Pushko PM; Tsibinogin VV; Pumpen PP
    Mol Biol (Mosk); 1991; 25(2):368-74. PubMed ID: 1715509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elicitation of bovine antibody to BLV-gp51 by BLV-vaccination.
    Maruyama K; Fukushima T; Mochizuki S; Abe H; Onuma M; Hasegawa A; Misawa M
    Leukemia; 1988 Dec; 2(12 Suppl):216S-222S. PubMed ID: 2848999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human homologue of the bovine leukemia virus receptor BLVRcp1 is the delta-subunit of adaptor-related AP-3 protein that does not bind the BVLgp51.
    Ban J; Hlavaty J; Orlik O; Splitter GA; Altaner C
    Arch Virol; 1999; 144(10):2013-22. PubMed ID: 10550673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bovine leukemia virus (BLV) envelope glycoprotein gp51 as a general model for the design of a subunit vaccine against retroviral infection: mapping of functional sites through immunological and structural data.
    Callebaut I; Mornon JP; Burny A; Portetelle D
    Leukemia; 1994 Apr; 8 Suppl 1():S218-21. PubMed ID: 7512181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.